XENE 10-Q: SEC filing

Xenon Pharmaceuticals

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-453701

XENE filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +3.3% by the first close after the filing.

Summary of the filing

Xenon Pharmaceuticals filed its quarterly 10-Q report for Q3 2026, disclosing financial results, cash position, and ongoing clinical development activities including its azetukalner program.

For details, click here →How to read a 10-Q →

Key details

FilerXenon Pharmaceuticals Inc.

License and collaboration partnerNeurocrine Biosciences

Asset purchase agreement counterpartyFirst Order Pharmaceuticals Inc.

ExecutiveIan Mortimer

How XENE stock reacted

Close before

$39.17

Nov 6, 2026

First close after

+3.27%

$40.45

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for XENE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for XENE?

Click here

Frequently asked questions

What did XENE file with the SEC on Nov 9, 2026?

XENE filed a 10-Q (SEC filing). Xenon Pharmaceuticals filed its quarterly 10-Q report for Q3 2026, disclosing financial results, cash position, and ongoing clinical development activities including its azetukalner program.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did XENE stock react to this filing?

XENE closed at $39.17 before the filing and $40.45 on Nov 9, 2026 (+3.27%).

Other XENE SEC filings

Get alerts when XENE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

XENE overview XENE analysis XENE news Latest SEC filings